BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34792725)

  • 1. Intraoperative irradiation in breast cancer: preliminary results in 80 patients as partial breast irradiation or anticipated boost prior to hypo-fractionated whole breast irradiation.
    Li X; Sanz J; Argudo N; Vernet-Tomas M; Rodríguez N; Torrent L; Fernández-Velilla E; Pera O; Huang Y; Nicolau P; Jiménez M; Segura M; Algara M
    Clin Transl Oncol; 2022 May; 24(5):829-835. PubMed ID: 34792725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
    Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
    Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis.
    Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Santana C; Ospina J; Lara PC
    Clin Transl Oncol; 2021 Jan; 23(1):179-182. PubMed ID: 32445034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated whole breast irradiation after IORT treatment is safe in patients receiving adjuvant chemotherapy.
    Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Murias C; Santana C; Ospina J; Lara PC
    Clin Transl Oncol; 2021 Dec; 23(12):2579-2583. PubMed ID: 34091868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actual benefit of intraoperative radiation therapy using 50 kV x-rays in early breast cancer: A retrospective study of 676 patients.
    Tallet A; Racadot S; Boher JM; Cohen M; Barrou J; Houvenaeghel G; Gutowski M; Delmond L; Lemanski C
    Breast J; 2020 Nov; 26(11):2145-2150. PubMed ID: 32233012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
    Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
    Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
    Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
    Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials.
    Haussmann J; Budach W; Corradini S; Krug D; Jazmati D; Tamaskovics B; Bölke E; Pedotoa A; Kammers K; Matuschek C
    Radiat Oncol; 2023 Nov; 18(1):181. PubMed ID: 37919752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of partial-breast irradiation and intraoperative radiation to whole-breast irradiation in early-stage breast cancer patients: a Kaplan-Meier-derived patient data meta-analysis.
    Ravani LV; Calomeni P; Wang M; Deng D; Speers C; Zaorsky NG; Shah C
    Breast Cancer Res Treat; 2024 Jan; 203(1):1-12. PubMed ID: 37736843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer.
    Hochhertz F; Hass P; Röllich B; Ochel HJ; Gawish A
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5743-5749. PubMed ID: 36566484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis.
    Stoian R; Erbes T; Zamboglou C; Scholber J; Gainey M; Sachpazidis I; Haehl E; Spohn SKB; Verma V; Krug D; Rühle A; Juhasz-Böss I; Grosu AL; Nicolay NH; Sprave T
    Strahlenther Onkol; 2021 Sep; 197(9):812-819. PubMed ID: 33938966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer.
    Chang DW; te Marvelde L; Chua BH
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):73-9. PubMed ID: 24331652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer.
    Fastner G; Gaisberger C; Kaiser J; Scherer P; Ciabattoni A; Petoukhova A; Sperk E; Poortmans P; Calvo FA; Sedlmayer F; Leonardi MC
    Radiother Oncol; 2020 Aug; 149():150-157. PubMed ID: 32413529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative radiotherapy (IORT) as boost in breast cancer.
    Sedlmayer F; Reitsamer R; Wenz F; Sperk E; Fussl C; Kaiser J; Ziegler I; Zehentmayr F; Deutschmann H; Kopp P; Fastner G
    Radiat Oncol; 2017 Jan; 12(1):23. PubMed ID: 28103903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five Fraction Accelerated Partial Breast Irradiation Versus Intraoperative Radiation Therapy for Early-Stage Breast Cancer.
    Halima A; Parker S; Fane L; Sayed S; Hall EF; Obi E; Figueroa B; Al-Hilli Z; Valente S; Gentle C; Cherian S; Tendulkar R; Shah C
    Clin Breast Cancer; 2024 Jan; 24(1):79-84. PubMed ID: 37914593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Schoeber C; Schaefer J; Steil V; Wenz F
    BMC Cancer; 2007 Sep; 7():178. PubMed ID: 17854511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients.
    Ahn SG; Bae SJ; Lee HW; Yoon CI; Kim JW; Lee IJ; Jeong J
    Breast Cancer Res Treat; 2019 Feb; 174(1):157-163. PubMed ID: 30467660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.